292 related articles for article (PubMed ID: 25938762)
1. A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice.
Milligan GN; Sarathy VV; Infante E; Li L; Campbell GA; Beatty PR; Harris E; Barrett AD; Bourne N
PLoS One; 2015; 10(5):e0125476. PubMed ID: 25938762
[TBL] [Abstract][Full Text] [Related]
2. A lethal model of disseminated dengue virus type 1 infection in AG129 mice.
Milligan GN; Sarathy VV; White MM; Greenberg MB; Campbell GA; Pyles RB; Barrett ADT; Bourne N
J Gen Virol; 2017 Oct; 98(10):2507-2519. PubMed ID: 28949904
[TBL] [Abstract][Full Text] [Related]
3. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.
Sarathy VV; White M; Li L; Gorder SR; Pyles RB; Campbell GA; Milligan GN; Bourne N; Barrett AD
J Virol; 2015 Jan; 89(2):1254-66. PubMed ID: 25392217
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a murine model of non-lethal, symptomatic dengue virus infection.
Sarathy VV; White M; Li L; Kaiser JA; Campbell GA; Milligan GN; Bourne N; Barrett ADT
Sci Rep; 2018 Mar; 8(1):4900. PubMed ID: 29559699
[TBL] [Abstract][Full Text] [Related]
5. Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model.
Sarathy VV; Infante E; Li L; Campbell GA; Wang T; Paessler S; Robert Beatty P; Harris E; Milligan GN; Bourne N; Barrett ADT
J Gen Virol; 2015 Oct; 96(10):3035-3048. PubMed ID: 26296350
[TBL] [Abstract][Full Text] [Related]
6. Mouse models of dengue virus infection for vaccine testing.
Sarathy VV; Milligan GN; Bourne N; Barrett AD
Vaccine; 2015 Dec; 33(50):7051-60. PubMed ID: 26478201
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of activity testing for therapeutics against all four dengue virus serotypes in AG129 mouse models: Proof-of-concept studies with the adenosine nucleoside inhibitor NITD-008.
Milligan GN; White M; Zavala D; Pyles RB; Sarathy VV; Barrett ADT; Bourne N
Antiviral Res; 2018 Jun; 154():104-109. PubMed ID: 29665374
[TBL] [Abstract][Full Text] [Related]
8. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.
Zellweger RM; Tang WW; Eddy WE; King K; Sanchez MC; Shresta S
J Virol; 2015 Jun; 89(12):6494-505. PubMed ID: 25855749
[TBL] [Abstract][Full Text] [Related]
10. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.
Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS
mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1).
Gelanew T; Hunsperger E
Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531
[TBL] [Abstract][Full Text] [Related]
12. Infant mouse brain passaged Dengue serotype 2 virus induces non-neurological disease with inflammatory spleen collapse in AG129 mice after splenic adaptation.
Rajmane Y; Shaikh S; Basha K; Reddy GE; Nair S; Kamath S; Sreejesh G; Rao H; Ramana V; Kumar AS
Virus Res; 2013 May; 173(2):386-97. PubMed ID: 23337909
[TBL] [Abstract][Full Text] [Related]
13. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
[TBL] [Abstract][Full Text] [Related]
14. The Role of Heterotypic DENV-specific CD8
Talarico LB; Batalle JP; Byrne AB; Brahamian JM; Ferretti A; García AG; Mauri A; Simonetto C; Hijano DR; Lawrence A; Acosta PL; Caballero MT; Paredes Rojas Y; Ibañez LI; Melendi GA; Rey FA; Damonte EB; Harris E; Polack FP
EBioMedicine; 2017 Jun; 20():202-216. PubMed ID: 28483582
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans.
Moi ML; Takasaki T; Omatsu T; Nakamura S; Katakai Y; Ami Y; Suzaki Y; Saijo M; Akari H; Kurane I
J Gen Virol; 2014 Mar; 95(Pt 3):591-600. PubMed ID: 24323638
[TBL] [Abstract][Full Text] [Related]
16. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
[TBL] [Abstract][Full Text] [Related]
17. Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.
Zompi S; Santich BH; Beatty PR; Harris E
J Immunol; 2012 Jan; 188(1):404-16. PubMed ID: 22131327
[TBL] [Abstract][Full Text] [Related]
18. Callithrix penicillata: a feasible experimental model for dengue virus infection.
Ferreira MS; de Castro PH; Silva GA; Casseb SM; Dias Júnior AG; Rodrigues SG; Azevedo Rdo S; Costa e Silva MF; Zauli DA; Araújo MS; Béla SR; Teixeira-Carvalho A; Martins-Filho OA; Vasconcelos PF
Immunol Lett; 2014; 158(1-2):126-33. PubMed ID: 24361035
[TBL] [Abstract][Full Text] [Related]
19. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage.
Chao CH; Wu WC; Lai YC; Tsai PJ; Perng GC; Lin YS; Yeh TM
PLoS Pathog; 2019 Apr; 15(4):e1007625. PubMed ID: 31009511
[TBL] [Abstract][Full Text] [Related]
20. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules.
Costa VV; Ye W; Chen Q; Teixeira MM; Preiser P; Ooi EE; Chen J
mBio; 2017 Aug; 8(4):. PubMed ID: 28765218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
